The Conquest of Cancer

We have harnessed the power of new technologies to identify genes involved in the development of cancers and forever change how we think about these diseases.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

For the first time since records have been kept, death rates from cancer in the United States have dropped--by some 2.6 percent between 1991 and 1995. These figures are encouraging when compared with cancer mortality rates recorded during the previous decade (1981-1990), which actually increased.

It is likely these successes result from several factors, including more effective methods of treating cancers; better, more widely used techniques to diagnose cancers early; and progress in the prevention of some cancers. Moreover, we have entered a period of unprecedented biological discovery. Perhaps most importantly, we have harnessed the power of new technologies to identify genes involved in the development of cancers and forever change how we think about these diseases.

Surgery, chemotherapy, and radiation therapy remain the mainstays of cancer treatment and continue to be improved. But today investigators are developing targeted cancer treatments, many of which home in on cancer cells while ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Paul Marks

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo